To assess the long term oncologic results of high-intensity focused ultrasound therapy (HIFU) as a primary and single treatment for clinically localized prostate cancer.
Department of Urology of Pitié-Salpétrière Hospital, Groupe Hospitalo-Univeristaire EST, Assistance Publique-Hôpitaux de Paris; Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France.